Enhanced osteoinductivity of recombinant human bone morphogenetic protein-2 in combination with epidermal growth factor in a rabbit tibial defect model

References

• Benglis D, Wang MY, Levi AD. 2008. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62:423–431
   Google Scholar
• Bottcher RT, Niehrs C. 2005. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 26:63–77
   PubMed Web of Science ®Google Scholar
• Carragee EJ, Hurwitz EL, Weiner BK. 2011. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 11:471–491
   PubMed Web of Science ®Google Scholar
• Choi IH, Cho TJ, Moon HJ. 2011. Ilizarov treatment of congenital pseudarthrosis of the tibia: A multi-targeted approach using the Ilizarov technique. Clin Orthop Surg 3:1–8
   PubMedGoogle Scholar
• Corenman DS, Gillard DM, Dornan G, Strauch E. 2013. Recombinant human BMP-2-augmented transforaminal lumbar interbody fusion for the treatment of chronic low back pain secondary to the homogeneous diagnosis of discogenic pain syndrome: Two-year outcomes. Spine 38:E1269–E1277
   Google Scholar
• Helgeson MD, Lehman RA Jr, Patzkowski JC, Dmitriev AE, Rosner MK, Mack AW. 2011. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. Spine J 11:507–510
   Google Scholar
• Kim SJ, Kim SY, Kwon CH, Kim YK. 2007. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Growth Factors 25:77–86
   PubMed Web of Science ®Google Scholar
• Laflamme C, Curt S, Rouabhia M. 2010. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol 55:689–701
   PubMed Web of Science ®Google Scholar
• Lee JH. Jang SJ, Baek HR, Lee KM, Chang BS, Lee CK. 2014. Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor. J Tissue Eng Reg Med [Epub ahead of print]
   Google Scholar
• Lee MJ, Sohn SK, Kim KT, Kim CH, Ahn HB, Rho MS, Jeong MH, Sun SK. 2010. Effect of hydroxyapatite on bone integration in a rabbit tibial defect model. Clin Orthop Surg 2:90–97
   PubMedGoogle Scholar
• Lieberman JR, Daluiski A, Einhorn TA. 2002. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84:1032–1044
   PubMed Web of Science ®Google Scholar
• Moghaddam-Alvandi A, Zimmermann G, Buchler A, Elleser C, Biglari B, Grutzner PA, Wolfl CG. 2012. Results of nonunion treatment with bone morphogenetic protein 7 (BMP-7). Der Unfallchirurg 115:518–526
   Google Scholar
• Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T. 1995. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276–1284
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. 2005. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36:399–407
   PubMed Web of Science ®Google Scholar
• Rodan SB, Wesolowski G, Thomas KA, Yoon K, Rodan GA. 1989. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 20:283–288
   PubMed Web of Science ®Google Scholar
• Smoljanovic T, Rakovac M, Bojanic I. 2011. Could chronic host inflammatory response be responsible for delayed onset of retrograde ejaculation after the labeled use of recombinant human bone morphogenetic protein-2? Spine J 11:167–168
   Google Scholar
• Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. 2006. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem cells 24:686–695
   PubMed Web of Science ®Google Scholar
• Wang K, Yamamoto H, Chin JR, Werb Z, Vu TH. 2004. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem 279:53848–53856
   PubMed Web of Science ®Google Scholar
• Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, et al. 2008. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol 217:409–422
   Google Scholar
• Zhang X, Tamasi J, Lu X, Zhu J, Chen H, Tian X, Lee TC, et al. 2011. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. J Bone Miner Res 26:1022–1034
   PubMed Web of Science ®Google Scholar
• Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L. 2011. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 112:1749–1760
   PubMed Web of Science ®Google Scholar